RTW Investments Overview
- Investor Type
-
Hedge Fund
- Status
-
Active
- Professionals
-
20
- Investments
-
169
- Portfolio
-
39
- Exits
-
106
RTW Investments General Information
Company Description
Founded in 2009, RTW Investments is a hedge fund manager firm based in New York. The firm primarily focuses on a sector-oriented strategy focusing on life sciences, big data, and digital health sectors across the United States and Europe.
Business Details
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 40 10th Avenue
- Floor 7
- New York, NY 10014
- United States
RTW Investments Investments & Acquisitions (169)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Neurosterix | 11-Nov-2026 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Mentari Therapeutics | 06-Nov-2026 | Drug Discovery | Generating Revenue | |||
| Mentari Therapeutics | 06-Nov-2026 | Drug Discovery | Generating Revenue | |||
| Lyell Immunopharma | 04-Nov-2026 | Drug Discovery | Generating Revenue | |||
| Zai Lab | 27-Oct-2026 | Pharmaceuticals | Profitable | |||
| Anaheim Bio | 01-Oct-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Korsana Biosciences | 07-Sep-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Slate Medicines | 17-Aug-2026 | Biotechnology | Clinical Trials - Phase 1 | |||
| Avere Therapeutics | 10-Aug-2026 | PE Growth/Expansion | Drug Discovery | Generating Revenue | ||
| Tarsus Pharmaceuticals | 05-Aug-2026 | PIPE | Pharmaceuticals | Generating Revenue |
RTW Investments Exits (106)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Windward Bio Group | 03-Nov-2026 | IPO | |
| Lycia Therapeutics | 23-Oct-2026 | ||
| Pyxis Oncology | 01-Oct-2026 | ||
| Mantle Therapeutics | 23-Sep-2026 | ||
| Alesta Therapeutics | 01-Sep-2026 | ||
| Yarrow Bioscience | 13-Aug-2026 | ||
| Abdera Therapeutics | 07-Aug-2026 | ||
| Obsidian Therapeutics | 03-Aug-2026 | ||
| Crescent Biopharma | 16-Jul-2026 | Public Investment 2nd Offering | |
| Neurogene | 02-Jul-2026 | Public Investment 2nd Offering |
RTW Investments Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
RTW Investments Co-Investors (216)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Janus Henderson Investors | 12 |
|
|
||
| RA Capital Management |
|
|
|||
| Invus (Private Equity) |
|
|
|||
| OrbiMed |
|
|
|||
| Perceptive Advisors |
|
|
RTW Investments Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| RTW Biotech Opportunities | Saint Peter Port, United Kingdom | 2017 |
RTW Investments FAQs
-
What is RTW Investments?
Founded in 2009, RTW Investments is a hedge fund manager firm based in New York.
-
When was RTW Investments founded?
RTW Investments was founded in 2009.
-
Where is RTW Investments headquartered?
RTW Investments is headquartered in New York, NY.
-
What is RTW Investments's total asset value?
RTW Investments has around in total assets under management.
-
How many investments has RTW Investments made?
RTW Investments has made 169 investments.
-
What has RTW Investments invested in?
RTW Investments has made numerous investments in companies like Neurosterix, Mentari Therapeutics, and Lyell Immunopharma within the Drug Discovery industry.
-
What has RTW Investments invested in recently?
RTW Investments's latest investment was on 11-Nov-2026 in Neurosterix, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
